China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 29.76
+0.04 (0.13%)
May 13, 2025, 2:45 PM CST
SHA:600511 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 2,000 | 2,000 | 2,146 | 1,964 | 1,754 | 1,383 | Upgrade
|
| Depreciation & Amortization | 231.94 | 231.94 | 199.75 | 189.61 | 178.83 | 172.6 | Upgrade
|
| Other Amortization | 18.13 | 18.13 | 8.57 | 7.84 | - | 5.13 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.19 | 0.19 | -0.08 | -1.68 | - | -0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0 | 0 | 0.05 | 5.23 | - | 6.5 | Upgrade
|
| Loss (Gain) From Sale of Investments | -532.08 | -532.08 | -369.77 | -291.62 | - | -220.6 | Upgrade
|
| Provision & Write-off of Bad Debts | 22.82 | 22.82 | 9.17 | 23.8 | - | 9.32 | Upgrade
|
| Other Operating Activities | -8.56 | 164.38 | 228.17 | 203.37 | 24.54 | 164.44 | Upgrade
|
| Change in Accounts Receivable | -442.42 | -442.42 | -292.55 | 599.77 | - | -107.14 | Upgrade
|
| Change in Inventory | -993.86 | -993.86 | -243.6 | -207.59 | - | 300.41 | Upgrade
|
| Change in Accounts Payable | 1,218 | 1,218 | 1,048 | -87.62 | - | -411.41 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 0.77 | Upgrade
|
| Operating Cash Flow | 1,486 | 1,659 | 2,727 | 2,395 | 1,957 | 1,302 | Upgrade
|
| Operating Cash Flow Growth | -30.94% | -39.15% | 13.84% | 22.36% | 50.38% | -26.71% | Upgrade
|
| Capital Expenditures | -118.52 | -130.77 | -145.12 | -129.78 | -95.07 | -69.05 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.34 | 0.39 | 0.16 | 3.52 | 0.78 | 1.3 | Upgrade
|
| Cash Acquisitions | - | - | - | -15.2 | -15.82 | 1.21 | Upgrade
|
| Investment in Securities | -2,491 | -2,477 | 7.88 | -12.6 | -15.75 | 2.87 | Upgrade
|
| Other Investing Activities | 23.75 | 23.75 | 7.77 | 1.74 | 2.86 | 7.21 | Upgrade
|
| Investing Cash Flow | -2,586 | -2,584 | -129.31 | -152.32 | -122.99 | -56.47 | Upgrade
|
| Short-Term Debt Issued | - | 315.98 | 203.2 | 335.61 | 793.18 | 1,184 | Upgrade
|
| Total Debt Issued | 406.45 | 315.98 | 203.2 | 335.61 | 793.18 | 1,184 | Upgrade
|
| Short-Term Debt Repaid | - | -1,033 | -250 | -509.86 | -864.55 | -1,061 | Upgrade
|
| Long-Term Debt Repaid | - | -117.81 | -81.71 | -117.07 | -72.35 | -60.05 | Upgrade
|
| Total Debt Repaid | -1,219 | -1,151 | -331.71 | -626.93 | -936.91 | -1,121 | Upgrade
|
| Net Debt Issued (Repaid) | -813.05 | -835.11 | -128.51 | -291.32 | -143.72 | 62.86 | Upgrade
|
| Common Dividends Paid | -657.12 | -682.43 | -709.58 | -611.96 | -637.77 | -613.06 | Upgrade
|
| Other Financing Activities | -355.28 | -64.8 | 205.91 | 263.71 | 35.53 | -180.41 | Upgrade
|
| Financing Cash Flow | -1,825 | -1,582 | -632.18 | -639.57 | -745.96 | -730.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.02 | Upgrade
|
| Net Cash Flow | -2,925 | -2,507 | 1,965 | 1,603 | 1,088 | 514.57 | Upgrade
|
| Free Cash Flow | 1,367 | 1,528 | 2,582 | 2,265 | 1,862 | 1,233 | Upgrade
|
| Free Cash Flow Growth | -31.92% | -40.80% | 13.96% | 21.64% | 51.09% | -27.08% | Upgrade
|
| Free Cash Flow Margin | 2.67% | 3.02% | 5.20% | 4.98% | 4.01% | 3.05% | Upgrade
|
| Free Cash Flow Per Share | 1.81 | 2.03 | 3.42 | 3.00 | 2.47 | 1.63 | Upgrade
|
| Cash Income Tax Paid | 1,497 | 1,479 | 1,450 | 1,350 | 1,300 | 1,248 | Upgrade
|
| Levered Free Cash Flow | -437.21 | 14.86 | 2,185 | 2,073 | 1,497 | 623.65 | Upgrade
|
| Unlevered Free Cash Flow | -416.18 | 35.89 | 2,205 | 2,089 | 1,524 | 659.16 | Upgrade
|
| Change in Net Working Capital | 1,864 | 1,399 | -659.09 | -572.62 | -156.24 | 428.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.